Invention Grant
- Patent Title: Compositions and methods for enhancing macrophage-mediated antibody guided cancer cell or tumor eradication
-
Application No.: US16631041Application Date: 2018-07-12
-
Publication No.: US11667900B2Publication Date: 2023-06-06
- Inventor: Yingxiao Wang , Shu Chien , Lei Lei , Shaoying Lu , Jie Sun
- Applicant: The Regents of the University of California
- Applicant Address: US CA Oakland
- Assignee: The Regents of the University of California
- Current Assignee: The Regents of the University of California
- Current Assignee Address: US CA Oakland
- Agency: Greer, Burns & Crain, Ltd.
- Agent Gregory P. Einhorn
- International Application: PCT/US2018/041766 2018.07.12
- International Announcement: WO2019/014419A 2019.01.17
- Date entered country: 2020-01-14
- Main IPC: C12N9/16
- IPC: C12N9/16 ; A61K38/00 ; A61K39/395 ; C07K14/435

Abstract:
Provided are Shp2- and Spleen tyrosine kinase (Syk)-integrated sensing and actuating protein (iSNAP) (Shp2- and Syk-iSNAP) chimeric proteins comprising: a bi-phosphorylatable peptide, optionally a bisphosphoryl tyrosine-based activation (BTAM) motif; a Fluorescent Protein (FP) Förster Resonance Energy Transfer (FRET) (or FP FRET) pair or pair of motifs; a truncated Shp2 domain comprising an N-Src Homology 2(N-SH2) domain and a C-Src Homology 2(C-SH2) domain; and, a phosphatase (PTP) domain or a kinase domain. Provided are engineered cells and methods for cancer cell or tumor eradication, or for the treatment or amelioration of a cancer, tumor or dysfunctional cell, or for promoting an anti-cancer, anti-tumor or anti-dysfunctional cell inflammatory response, including enhancing macrophage-, monocyte-, microglia-, osteoclast-, Kupffer cell- or dendritic cell-mediated antibody- or monoclonal antibody (mAb)-guided cancer or dysfunctional cell or tumor eradication, amelioration, or treatment.
Information query